Search results
Novavax failed to capitalize on fears surrounding mRNA vaccines, activist investor says
Market Watch· 1 week agovaccine-maker’s management, as it called for an overhaul of the company’s marketing strategy to...
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
Quartz· 1 week agoThe activist hedge fund Shah Capital blasted the leadership of Novavax for not leveraging concerns...
Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?
Zacks via Yahoo Finance· 2 weeks agoTo extend its existing cash runway and curb cash burn, Novavax (NVAX) initiates multiple...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 7 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Who can get a Covid booster this spring and how can you book?
BBC via AOL· 1 week agoThe most common include a sore arm, headache, chills, fatigue and nausea. They are part of the...
Down 60% From Its 52-Week High, Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 2 weeks agoNovavax continues to focus on COVID Novavax has an approved COVID-19 vaccine and it's bullish on a...
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life· 3 days agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...
COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids
MedPage Today· 21 hours agoData gathered from over 4 million children revealed that myocarditis or pericarditis occurred at...
Shah Capital proposes new directors for Novavax board By Investing.com
Investing.com· 1 week agoShah Capital, holding a 6.7% stake in vaccine developer Novavax Inc. (NASDAQ: NASDAQ:NVAX), today...
Only One Harm From mRNA COVID Vaccines, Report Determines
MedPage Today· 1 week agoIndependent reviewers confirmed a causal relationship between the first mRNA COVID-19 vaccines and...